US EditionPublished • loading... • Updated
Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA
Summary by QUICK NEWS AFRICA
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, and its long-standing partner Celltrion Inc., a global biopharmaceutical leader, have signed exclusive licensing agreements across the Middle East and North Africa (MENA) region. The new agreements will broaden access to cutting-edge and affordable biologics through the introduction of six biosimilar treatments to the region. This also […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
